Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Cutting expenses is essential for paying off credit cards. Discover practical tips to reduce your spending and regain financial control.
20,606 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
When a CFO discloses a sizable stake sale during a volatile period, investors scramble for context. This article brea...
In 2025, Marathon Petroleum delivered a powerful cash-return story for shareholders. This article breaks down how the...
Retirees chasing EDIV’s yield are flocking to emerging markets for higher income, but the strategy embeds currency ri...
Planet Labs stock popped today after a standout quarter and optimism about a path to profitability. This article brea...
Emerging markets can surprise investors with big moves. This article explains how a notable fund outpaced its benchma...
Last month, poet technologies skyrocketed 72.6%, delivering a dramatic rally in a volatile sector. This article expla...
Micron Technology has been a market darling, but a different S&P 500 stock has surged even more this year. This guide...
A small AI-focused player claims it helps customers turn modest marketing spend into impressive gains. This piece bre...
A tariff reversal can trigger a short-lived stock market surge, but gains often fade as details unfold. This guide ex...
A top AI stock has pulled back while earnings surge, drawing attention from analysts who see significant upside ahead...
Palantir is venturing into a new market via Polymarket, sparking questions about its AI growth path. This guide lays ...